A promising approach to effectively reduce cramp susceptibility in human muscles: a randomized, controlled clinical trial.

<h4>Background</h4>To investigate if the cramp threshold frequency (CTF) can be altered by electrical muscle stimulation in a shortened position.<h4>Methods</h4>A total of 15 healthy male sport students were randomly allocated to an intervention (IG, n = 10) and a non-treatme...

Full description

Saved in:
Bibliographic Details
Main Authors: Michael Behringer, Markus Moser, Molly McCourt, Johannes Montag, Joachim Mester
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0094910&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850142913768456192
author Michael Behringer
Markus Moser
Molly McCourt
Johannes Montag
Joachim Mester
author_facet Michael Behringer
Markus Moser
Molly McCourt
Johannes Montag
Joachim Mester
author_sort Michael Behringer
collection DOAJ
description <h4>Background</h4>To investigate if the cramp threshold frequency (CTF) can be altered by electrical muscle stimulation in a shortened position.<h4>Methods</h4>A total of 15 healthy male sport students were randomly allocated to an intervention (IG, n = 10) and a non-treatment control group (CG, n = 5). Calf muscles of both legs in the IG were stimulated equally twice a week over 6 weeks. The protocol was 3×5 s on, 10 s off, 150 µs impulse width, 30 Hz above the individual CTF, and was at 85% of the maximal tolerated stimulation energy. One leg was stimulated in a shortened position, inducing muscle cramps (CT), while the opposite leg was fixated in a neutral position at the ankle, hindering muscle cramps (nCT). CTF tests were performed prior to the first and 96 h after the 6(th) (3 w) and 12(th) (6 w) training session.<h4>Results</h4>After 3 w, the CTF had significantly (p<0.001) increased in CT calves from 23.3±5.7 Hz to 33.3±6.9 Hz, while it remained unchanged in nCT (pre: 23.6±5.7 Hz, mid: 22.3±3.5 Hz) and in both legs of the CG (pre: 21.8±3.2 Hz, mid: 22.0±2.7 Hz). Only CT saw further insignificant increases in the CTF. The applied stimulation energy (mA² • µs) positively correlated with the effect on the CTF (r = 0.92; p<0.001).<h4>Conclusions</h4>The present study may be useful for developing new non-pharmacological strategies to reduce cramp susceptibility.<h4>Trial registry</h4>German Clinical Trials Register DRKS00005312.
format Article
id doaj-art-a79917ea216041f5b7012b2dea9e5969
institution OA Journals
issn 1932-6203
language English
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-a79917ea216041f5b7012b2dea9e59692025-08-20T02:28:54ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0194e9491010.1371/journal.pone.0094910A promising approach to effectively reduce cramp susceptibility in human muscles: a randomized, controlled clinical trial.Michael BehringerMarkus MoserMolly McCourtJohannes MontagJoachim Mester<h4>Background</h4>To investigate if the cramp threshold frequency (CTF) can be altered by electrical muscle stimulation in a shortened position.<h4>Methods</h4>A total of 15 healthy male sport students were randomly allocated to an intervention (IG, n = 10) and a non-treatment control group (CG, n = 5). Calf muscles of both legs in the IG were stimulated equally twice a week over 6 weeks. The protocol was 3×5 s on, 10 s off, 150 µs impulse width, 30 Hz above the individual CTF, and was at 85% of the maximal tolerated stimulation energy. One leg was stimulated in a shortened position, inducing muscle cramps (CT), while the opposite leg was fixated in a neutral position at the ankle, hindering muscle cramps (nCT). CTF tests were performed prior to the first and 96 h after the 6(th) (3 w) and 12(th) (6 w) training session.<h4>Results</h4>After 3 w, the CTF had significantly (p<0.001) increased in CT calves from 23.3±5.7 Hz to 33.3±6.9 Hz, while it remained unchanged in nCT (pre: 23.6±5.7 Hz, mid: 22.3±3.5 Hz) and in both legs of the CG (pre: 21.8±3.2 Hz, mid: 22.0±2.7 Hz). Only CT saw further insignificant increases in the CTF. The applied stimulation energy (mA² • µs) positively correlated with the effect on the CTF (r = 0.92; p<0.001).<h4>Conclusions</h4>The present study may be useful for developing new non-pharmacological strategies to reduce cramp susceptibility.<h4>Trial registry</h4>German Clinical Trials Register DRKS00005312.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0094910&type=printable
spellingShingle Michael Behringer
Markus Moser
Molly McCourt
Johannes Montag
Joachim Mester
A promising approach to effectively reduce cramp susceptibility in human muscles: a randomized, controlled clinical trial.
PLoS ONE
title A promising approach to effectively reduce cramp susceptibility in human muscles: a randomized, controlled clinical trial.
title_full A promising approach to effectively reduce cramp susceptibility in human muscles: a randomized, controlled clinical trial.
title_fullStr A promising approach to effectively reduce cramp susceptibility in human muscles: a randomized, controlled clinical trial.
title_full_unstemmed A promising approach to effectively reduce cramp susceptibility in human muscles: a randomized, controlled clinical trial.
title_short A promising approach to effectively reduce cramp susceptibility in human muscles: a randomized, controlled clinical trial.
title_sort promising approach to effectively reduce cramp susceptibility in human muscles a randomized controlled clinical trial
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0094910&type=printable
work_keys_str_mv AT michaelbehringer apromisingapproachtoeffectivelyreducecrampsusceptibilityinhumanmusclesarandomizedcontrolledclinicaltrial
AT markusmoser apromisingapproachtoeffectivelyreducecrampsusceptibilityinhumanmusclesarandomizedcontrolledclinicaltrial
AT mollymccourt apromisingapproachtoeffectivelyreducecrampsusceptibilityinhumanmusclesarandomizedcontrolledclinicaltrial
AT johannesmontag apromisingapproachtoeffectivelyreducecrampsusceptibilityinhumanmusclesarandomizedcontrolledclinicaltrial
AT joachimmester apromisingapproachtoeffectivelyreducecrampsusceptibilityinhumanmusclesarandomizedcontrolledclinicaltrial
AT michaelbehringer promisingapproachtoeffectivelyreducecrampsusceptibilityinhumanmusclesarandomizedcontrolledclinicaltrial
AT markusmoser promisingapproachtoeffectivelyreducecrampsusceptibilityinhumanmusclesarandomizedcontrolledclinicaltrial
AT mollymccourt promisingapproachtoeffectivelyreducecrampsusceptibilityinhumanmusclesarandomizedcontrolledclinicaltrial
AT johannesmontag promisingapproachtoeffectivelyreducecrampsusceptibilityinhumanmusclesarandomizedcontrolledclinicaltrial
AT joachimmester promisingapproachtoeffectivelyreducecrampsusceptibilityinhumanmusclesarandomizedcontrolledclinicaltrial